Globus Medical | GMED - 销售收入



金融业
股票价格
USD
资产
USD 5.49B
现金及等价物
USD 507.75M
销售成本
USD 271M
流动资产
USD 2.22B
流动负债
USD 479.35M
债务
USD 115.22M
EBIT
USD -45.97M
EBITDA
USD 279.84M
员工
5.3K
EPS每股收益
USD 1.34
股本和储备
USD 4.77B
销售毛利
USD 548.17M
债务利息支出
USD 5.49B
利息收入
USD 815K
贷款资金
USD 398K
市值
USD 11.03B
净收入
USD 151.57M
营业费用
USD 835.58M
营业利润
USD -45.97M
普通股股本
USD 135.67M
PE价格收益
22.31
税前利润
USD 157.07M
销售收入
USD 789.61M
销售和管理费用
USD 286.82M
股票
USD 810.9M
贸易债权人
USD 106.94M
应收帐款人
USD 739.28M


销售 更改 日
Abbott USD 12.59B 1.43B 2026-06
AtriCure USD 153.6M 12.4M 2026-06
Baxter International USD 2.96B 260M 2026-06
Becton, Dickinson and Co. USD 5B 300M 2026-06
Boston Scientific USD 5.44B 240M 2026-06
Dexcom USD 1.31B 120M 2026-06
Edwards Lifesciences USD 1.74B 90M 2026-06
Globus Medical USD 789.61M 29.76M 2026-06
Haemonetics USD 339M 7M 2026-06
Inogen USD 74.93M 504K 2024-09
Insulet USD 801.7M 40M 2026-06
Integra LifeSciences USD 418.8M 26.9M 2026-06
Intuitive Surgical USD 2.89B 120M 2026-06
J&J USD 25.31B 1.21B 2026-06
Medtronic USD 9.8B 800M 2026-03
Merit Medical Systems USD 418.8M 36.9M 2026-06
Orthofix International USD 219.91M 14.28M 2025-12
Stryker USD 6.6B 600M 2026-06
Tandem Diabetes Care USD 254.6M 7.38M 2026-06
Teleflex USD 570.3M 22M 2026-06
Zimmer Biomet Holdings USD 2.18B 90M 2026-06